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ABSTRACT Despite recent advances in our understanding of how Helicobacter pylori causes disease, the factors that allow this
pathogen to persist in the stomach have not yet been fully characterized. To identify new virulence factors in H. pylori, we gener-
ated low-infectivity variants of a mouse-colonizing H. pylori strain using the classical technique of in vitro attenuation. The re-
sultingvariantsandtheirhighlyinfectiousprogenitorbacteriawerethenanalyzedbyglobalgeneexpressionproﬁling.Thegene
expressionlevelsofﬁveopenreadingframes(ORFs)weresigniﬁcantlyreducedinlow-infectivityvariants,withthemostsigniﬁ-
cant changes observed for ORFs HP1583 and HP1582. These ORFs were annotated as encoding homologs of the Escherichia coli
vitamin B6 biosynthesis enzymes PdxA and PdxJ. Functional complementation studies with E. coli conﬁrmed H. pylori PdxA
and PdxJ to be bona ﬁde homologs of vitamin B6 biosynthesis enzymes. Importantly, H. pylori PdxA was required for optimal
growth in vitro and was shown to be essential for chronic colonization in mice. In addition to having a well-known metabolic
role, vitamin B6 is necessary for the synthesis of glycosylated ﬂagella and for ﬂagellum-based motility in H. pylori. Thus, for the
ﬁrsttime,weidentifyvitaminB6biosynthesisenzymesasnovelvirulencefactorsinbacteria.Interestingly, pdxAandpdxJor-
thologsarepresentinanumberofhumanpathogens,butnotinmammaliancells.WethereforeproposethatPdxA/Jenzymes
mayrepresentidealcandidatesfortherapeutictargetsagainstbacterialpathogens.
IMPORTANCE Approximately half of the world’s population is infected with H. pylori, yet how H. pylori bacteria establish
chronicinfectionsinhumanhostsremainselusive.Fromgenearraystudies,weidentiﬁedtwogenesasrepresentingpotentially
novel colonization factors for H. pylori. These genes encoded enzymes involved in the synthesis of vitamin B6, an important
moleculeformanymetabolicreactionsinlivingorganisms.LittleiscurrentlyknownregardingvitaminB6biosynthesisinhu-
man pathogens. We showed that mutant H. pylori bacteria lacking an enzyme involved in de novo vitamin B6 biosynthesis,
PdxA,wereunabletosynthesizemotilityappendages(ﬂagella)andwereunabletoestablishchroniccolonizationinmice.Thus,
thisworkidentiﬁesvitaminB6biosynthesisenzymesasnovelvirulencefactorsforbacterialpathogens.Interestingly,anumber
ofhumanpathogens,butnottheirmammalianhosts,possessthesegenes,whichsuggeststhatPdxenzymesmayrepresentideal
candidatesfornewtherapeutictargets.
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T
herearecurrentlyonlyalimitednumberofantibioticssuitable
for the routine treatment of Helicobacter pylori infection;
moreover, the efﬁcacies of these compounds have been severely
hinderedbytheriseinresistanceamongH.pyloriisolates(1,2).It
is therefore necessary to develop novel therapeutic and prophy-
lacticstrategiesforthemanagementofH.pylori-relateddisease.In
anefforttodevelopsuchstrategies,weneedtogreatlyenhanceour
understandingofthemolecularbasisofH.pyloriadaptationtothe
specialized niche of the gastric mucosa (3). In silico analyses have
been fruitful in this regard; however, they are not always accurate
(4).Thus,severalgroupshavecombinedgenomeinformationand
functional data derived from the use of molecular techniques to
shednewinsightsintodifferentfacetsofH.pylorivirulence(5–7).
Although these techniques are very powerful, they rely, among
other things, on the availability of H. pylori strains that can be
readily transformed in vitro. These strains are usually laboratory-
adapted isolates that are not able to colonize small rodents. To
overcome this problem, workers have used suckling mice, which
support the growth of highly transformable laboratory-adapted
H. pylori strains that do not colonize adult mice (5). Suckling
mice,however,haveunderdevelopedimmunesystemsanddonot
possess the normal ﬂora of adult animals, which may bias results
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tablishmentofinfectionoverthoserequiredforchroniccoloniza-
tion (5).
Historically, in vitro attenuation has been used as a strategy to
study how microorganisms cause disease (8, 9). This strategy has
the advantage of being applicable to any microorganism that can
be propagated in vitro. Moreover, when combined with modern
molecular techniques, such as whole-genome sequencing (10), it
has been possible to identify novel virulence factors in otherwise
well-characterized bacterial pathogens. The current study de-
scribes the use of a dual strategy of in vitro attenuation and gene
expression proﬁling for the identiﬁcation of novel virulence fac-
tors in H. pylori. Using this approach, we identiﬁed PdxA, an en-
zyme involved in de novo vitamin B6 biosynthesis, as being an
important factor required for the chronic colonization of mice by
H.pylori.AlthoughitiswidelyacceptedthatvitaminB6isacofac-
tor in a wide array of cellular metabolic reactions, this study is the
ﬁrsttodescribealinkbetweenthismetaboliteandbacterialpatho-
genesis. Speciﬁcally, we demonstrated that vitamin B6 is impor-
tant for ﬂagellar structure, glycosylation, and motility in a human
pathogen. Given that mammalian hosts are unable to perform de
novo vitamin B6 biosynthesis, we propose that this work opens
new avenues for the development of innovative therapeutic tar-
gets against bacterial pathogens.
RESULTS
Generation of low-infectivity isolates of H. pylori SS1 by pro-
longed in vitro passage. To identify novel colonization factors of
H. pylori, we applied the technique of in vitro attenuation to the
well-characterized mouse-colonizing SS1 strain (11). We ob-
served a progressive loss in the ability of H. pylori SS1 variants to
infect mice, with signiﬁcant reductions apparent both in the pro-
portion of mice infected and in gastric bacterial levels after 109
passages in vitro (Table 1) (P  0.0031 and P  0.0001, respec-
tively). By 179 subcultures, H. pylori SS1 isolates were no longer
abletocolonizemice.OnlyminordifferencesintheDNAproﬁles
were detected between low- and high-infectivity isolates (see
Fig. S1A and B in the supplemental material). Furthermore, no
differences were observed between isolates with regard to either
theirabilitiestoperformurease-mediatedprotectionagainstacid,
essentialforH.pyloricolonizationofthestomach(12),ortheirin
vitro growth properties (Fig. S1C and D).
Downregulationofgeneexpressioninlow-infectivityH.py-
lori SS1. To determine molecular changes correlating with de-
creased colonization in high-passage-number isolates, we per-
formed global gene expression proﬁling of high- and low-
infectivity isolates. The expression levels of ﬁve coding sequences
were found to be signiﬁcantly downregulated in low-infectivity
isolates compared to those of high-infectivity bacteria (Fig. 1A).
These genes encode proteins involved in vitamin B6 biosynthesis
(pdxJ, pdxA), iron metabolism (frpB1), restriction modiﬁcation
(hsdR), and autotransporter (vacA paralog) functions. The ex-
pression levels of these genes were conﬁrmed by quantitative re-
versetranscription-PCR(qRT-PCR)tobesigniﬁcantlyreducedin
low-infectivity H. pylori SS1 isolates (Fig. 1B). The reduction in
the expression levels of these genes correlated with a decrease in
infectivity,ﬁrstobservedinH.pylorivariantshavingundergoneat
least 109 in vitro subcultures, suggesting that the genes may en-
code factors that contribute to host colonization. The greatest
variations in signiﬁcance analysis of macroarray (SAM) scores
wereobservedforH.pyloripdxJandpdxA,annotatedasencoding
homologs of the vitamin B6 biosynthesis proteins PdxJ and PdxA
in Escherichia coli. As the role of vitamin B6 has not been exten-
sively studied in a bacterial pathogen, we chose to focus on the
functions of the proteins encoded by these genes, including their
roles in host colonization by H. pylori.
PdxJandPdxAareinvolvedindenovovitaminB6biosynthe-
sis in H. pylori. To determine whether H. pylori pdxJ and pdxA
encode bona ﬁde homologs of vitamin B6 biosynthesis enzymes,
we constructed isogenic H. pylori pdxA mutants (13) in several
laboratory-adapted (251, N6, G27) and mouse-colonizing (SS1
andX47-2AL)H.pyloristrains.Thesemutantscouldberecovered
onlywhenthegrowthmediumwassupplementedwithpyridoxal-
5=-phosphate (PLP), the product of PdxJ/PdxA activities. In con-
trast,despitenumerousattemptsandapproaches,wewereunable
to disrupt pdxJ, suggesting that this mutation may be lethal for
H. pylori bacteria (data not shown). It is possible that PdxJ may
have another vital function(s) besides the synthesis of vitamin B6,
as has been reported for certain other H. pylori proteins (14).
Alternatively,itispossiblethatdisruptionofpdxJmayhavedown-
streameffectsonpdxAexpression.InH.pylori,thepdxJandpdxA
genesareclusteredtogetheronthegenome,withthestopcodonof
pdxJ preceding the start codon of pdxA by just 1 nucleotide
(Fig.S2AandB).FromqRT-PCRanalyses,itappearsthatpdxAis
transcribed as part of a longer pdxJ-pdxA cotranscript (Fig. S2C).
We next investigated the growth properties of the H. pylori
pdxA mutants in vitro. In the absence of PLP supplementation,
H.pyloripdxAmutantsexhibitedslowergrowthinliquidmedium
thantheparentstrain(Fig.2AandB).Thisdefectcould,however,
beentirelycompensatedforbytheadditionofPLPtothemediaor
by complementation using insertion in cis of an intact copy of
pdxAintotheH.pylorigenome(Fig.2AandB).Thesedatasuggest
a role for H. pylori PdxA in de novo vitamin B6 biosynthesis. To
demonstrate deﬁnitively that pdxA and pdxJ encode homologs of
vitamin B6 biosynthesis enzymes in H. pylori, we used a cross-
TABLE 1 Mouse colonization experiments with low- and high-
infectivity H. pylori SS1 isolates
In vitro passage
no. of isolatea
Inoculum/mouse
(log10 CFU)
No. of mice
infected (total)b
Mean  SD log10
CFU recovered/gc
58 6.3 9 (10)d —e
8 5.0 9 (9) —
74 6.7 5 (5)d —
9 6.7 5 (5) —
109 4.6 3 (10)f 3.74  0.50g
15 4.6 10 (10) 6.08  0.52
179 5.5 0 (10)g 2.0h
24 5.5 9 (9) 6.46  0.8
a For each experiment, mice were separated into 2 groups, and each group was
inoculated with either a low- or high-infectivity H. pylori SS1 isolate.
b H. pylori infection was detected by culture and urease activity at 4 or 6 weeks
postchallenge.
c Bacterial load determinations were performed by quantitative culture. Mean values
were calculated from infected mice only (assay sensitivity, 3.0 log CFU/g).
d P  0.99.
e —, not determined.
f P  0.0031.
g P  0.0001.
h P  0.0003.
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mutants(CGSC8631andCGSC10027,respectively[15]).Forthis,
we transformed the E. coli mutants with IPTG (isopropyl--D-
thiogalactopyranoside)-inducible expression plasmids harboring
intact copies of either H. pylori pdxA or pdxJ. The untransformed
E. coli mutants were unable to grow on minimal medium without
PLP added (Fig. 2C). In contrast, E. coli pdxA and pdxJ mutant
bacteria that had been transformed with either H. pylori pdxA-o r
pdxJ-expressing plasmids, respectively, were able to grow nor-
mally on minimal medium containing IPTG without PLP added.
Thus, the ability of H. pylori pdxA and pdxJ to cross-complement
a PLP deﬁciency in E. coli provides functional evidence that these
genes encode vitamin B6 biosynthesis proteins in H. pylori.
PdxAisessentialforgastriccolonizationofC57BL/6miceby
H. pylori. To determine whether vitamin B6 biosynthesis is im-
portant for bacterial colonization, we performed mouse infection
studieswithH.pyloripdxAmutantsgeneratedonboththeSS1and
X47-2AL genetic backgrounds. In parallel, colonization experi-
ments were performed with mutants in the other putative coloni-
zation genes (Fig. 1A). Colonization efﬁciency was assessed by at
leasttwomethods:quantitativeculture,serology,and/orRT-PCR
(Fig. 3A).
Signiﬁcantly lower bacterial loads were observed in mice chal-
lengedwithanH.pylorivacAparalogmutant(P0.01),whereas
mutations in either frpB1 or hsdR had no signiﬁcant effects on in
vivo colonization by H. pylori (Fig. S3). Interestingly, the most
dramaticeffectsonH.pyloricolonizationwereobservedforH.py-
lori pdxA mutants. Indeed, H. pylori bacteria were not cultured
from the gastric biopsy specimens of mice inoculated with pdxA
mutants in either H. pylori strain at both 7 and 30 days postinfec-
tion(Fig.3BandC).Similarly,noIgGwasdetectableintheseraof
mice infected with H. pylori pdxA mutant bacteria at 30 days
postinfectionineitherofthestrainstested(Fig.3E).Interestingly,
however, low levels of colonization, as indicated by IgM titers,
were observed at day 7 postinfection in mice challenged with
H. pylori pdxA mutants on the X47-2AL genetic background,
whereas no evidence of colonization could be found for H. pylori
SS1 pdxA mutants (Fig. 3A and D). In both cases, however, the
H. pylori pdxA mutant bacteria were cleared by 30 days.
Complementation of H. pylori pdxA mutants with a wild-type
copyofpdxArestoredinfectivity,asdemonstratedbyasigniﬁcant
increaseinboththenumbersofmicecolonizedandtheserumIgG
levels at day 30 postinfection (Fig. 3B, C, and E) (P  0.05, P 
0.01, and P  0.01, respectively). Although the restoration of in-
FIG 1 Downregulation of gene expression in low-infectivity H. pylori SS1 isolates. (A) Radioactively labeled cDNA samples from paired low- and high-
infectivity H. pylori SS1 isolates were hybridized to macroarrays. TIGR numbers refer to the coding sequence numbers as identiﬁed by the J. Craig Venter
Institute. Score values represent the relative levels of signiﬁcance assigned by SAM analysis (34). Fold changes represent the fold changes between low- and
high-infectivityisolates(fourexperiments).(B)qRT-PCRanalysesofpdxA,pdxJ,frpB1,hsdR,andvacAparalogmRNAexpressioninliquidculturesofH.pylori
SS1isolateshavingundergonedifferentnumbersofpassages.Geneexpressionwasnormalizedtothehousekeepinggene,uvrC(35).Errorbarsindicatestandard
errors of the means (SEM) (three experiments). *, P  0.05; **, P  0.01.
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most likely be attributed to the reduced expression levels of pdxJ
observed in H. pylori pdxA mutant bacteria (Fig. S4A). Cumula-
tively, these data identify the essential role of PdxA in H. pylori
colonization of the mouse gastric mucosa.
Vitamin B6 contributes to motility and ﬂagellar glycosyla-
tion in H. pylori. We next wished to investigate the reason(s) for
the severe impairment in colonization efﬁciency of the H. pylori
pdxA mutants. Vitamin B6, or its active form, PLP, is classically
thought to be a cofactor for many metabolic enzymes and has
recently been identiﬁed as a cofactor of H. pylori PseC, an amino-
transferase involved in ﬂagellar glycosylation (16). Glycosylation
of ﬂagella is necessary for the assembly of functional ﬂagellar ﬁla-
ments, motility, and infectivity in H. pylori (17). Therefore, we
hypothesized that a defect in ﬂagellar structure or motility may
account for the impaired virulence in vivo of the H. pylori pdxA
mutants.Totestthishypothesis,weexaminedH.pylorimotilityin
soft agar plates and by live-cell imaging. For each of the H. pylori
strains tested (G27, X47-2AL, and SS1), parental bacteria were
motile, whereas H. pylori pdxA mutants were nonmotile (Fig. 4A)
(P 0.01). Addition of exogenous PLP to the motility media,
however, resulted in a diffuse growth pattern for H. pylori pdxA
mutants, indicative of motile bacteria (Fig. 4A). Consistent with
these ﬁndings, in the absence of PLP supplementation, parental
H. pylori bacteria exhibited an average velocity of 27.92 
1.437 m/s (see Movie S1 in the supplemental material), whereas
H.pyloripdxAmutantsmovedatanaveragevelocityofonly2.865
 0.5626 m/s (Fig. 4B; Movie S2) (P  0.0001). Supplementa-
tion of broth cultures with PLP restored the motility of H. pylori
pdxA mutants to an average velocity of 28.92  3.160 m/s
(Fig. 4B; Movie S3) (P  0.0001).
To determine whether the defect in motility of H. pylori pdxA
mutantswasaresultofalteredﬂagellarstructure,weexaminedthe
ﬂagella from H. pylori G27 parental and pdxA mutant bacteria.
Parental H. pylori bacteria and complemented pdxA mutants dis-
played polar, sheathed ﬂagella, whereas H. pylori pdxA mutants
appeared to express no ﬂagella (Fig. 5A to C), indicating a poten-
tialimpairmentinﬂagellarassembly.Toelucidatefurthertherole
ofvitaminB6intheproductionofﬂagella,weperformedWestern
blot analyses of whole-cell lysates and sheared ﬂagellar prepara-
tions using a monoclonal antibody directed against the major
H.pyloriﬂagellin,FlaA.Whole-celllysatespreparedfromH.pylori
X47-2AL pdxA mutants contained amounts of FlaA protein
equivalenttothoseinlysatespreparedfromparentalandcomple-
FIG2 InvitrogrowthofH.pyloripdxAmutantsandfunctionalcharacterizationofPdxJ/A.(AandB)InvitrogrowthpropertiesofH.pyloriG27wildtype(WT),
pdxA, and pdxA (pdxA) strains were determined in liquid media supplemented or not supplemented with PLP. At each time point, A600 readings (A) and
duplicate viable cell count determinations (B) were performed (three experiments). Data are presented as the log of the mean viable cell count (for each time
point)  SEM. (C) Growth of E. coli CGSC8631 (pdxA) and CGSC10027 (pdxJ) that had been transformed, or not, with pET28a pdxA and pET28a pdxJ,
respectively, in the presence or absence of PLP and IPTG.
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sheared ﬂagellar preparations from H. pylori pdxA bacteria con-
tained much less FlaA than those prepared from parental bacteria
(Fig. 5D). Consistent with previous work (18), exported H. pylori
FlaAproteinsintheﬂagellarpreparationsfromparentalandcom-
plementedH.pyloribacteriawereglycosylated,whereasFlaApro-
teins in the cytoplasm were nonglycosylated (Fig. 5E). Signiﬁ-
cantly, only the exported FlaA in the ﬂagellar preparations from
parental H. pylori bacteria, but not those from the pdxA mutant
organisms, were glycosylated (Fig. 5E). The data suggest that the
inabilityofH.pyloripdxAmutantstoglycosylateandexportfunc-
tional ﬂagellar ﬁlaments was not due to a defect in cellular FlaA
production but rather to the absence of a posttranslational mod-
iﬁcation that requires the PLP-dependent enzyme PseC. Taken
FIG 3 PdxA is required for colonization of mice by H. pylori. C57BL/6 mice (ﬁve per group) were inoculated with 107 CFU of H. pylori by intragastric gavage.
(A)Colonizationefﬁciencywasassessedbyculture,serology,and/orRT-PCR.,notdetermined.(BandC)Quantitativecultureassayswereperformedat7(B)
and 30 (C) days postinfection. Each point represents the mean of two estimations for a single mouse. Data are pooled from three separate experiments for
H. pylori SS1 and two separate experiments for H. pylori X47-2AL. Two independent H. pylori SS1 pdxA clones and two independent H. pylori X47-2AL pdxA
(pdxA) clones were used. Data are presented as log units (CFU/gram stomach). Horizontal bars represent the geometric means of viable cell count determi-
nations for each H. pylori strain. The limit of detection for the assay is 3 log CFU/gram. (D and E) Speciﬁc IgM (D) and IgG (E) class antibodies in the sera of
H.pylori-infectedmiceweredetectedbyELISAat7(D)and30(E)dayspostinfection.Dataarepresentedaslogsoftiters,correspondingtothereciprocalofthe
serumdilutiongivinganA595valuethatwas5-foldabovethatobtainedforbackgroundcontrols.HorizontalbarsrepresentthegeometricmeansforeachH.pylori
strain. The limit of detection for the assay is a log titer of 1.7. *, P  0.05; **, P  0.01; and ***, P  0.0001, as determined by the Mann-Whitney U test.
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tant for ﬂagellar biosynthesis and motility, which are vital for
H. pylori colonization of the gastric mucosa.
DISCUSSION
Thisstudyreportstheidentiﬁcationofnovelvirulencefactorsina
pathogenic bacterium using the classical approach of in vitro at-
tenuation in combination with global gene expression proﬁling.
Although some of the factors (i.e., HsdR and FrpB1) were not
essentialforcolonization,wesuggestthatthecumulativeeffectsof
loweredgeneexpressionlevelsfortheseandotherfactors,includ-
ing PdxA and the VacA paralog, are likely to have contributed to
the difference in colonization levels between the low- and high-
passage-numberisolatesofH.pyloriSS1.Mostimportantly,how-
FIG4 PdxAisrequiredformotilityinH.pylori.(A)Thebacterialmotilityofwild-typeandpdxAmutantstrainsondifferentH.pylorigeneticbackgroundswas
assayed using 0.4% (wt/vol) semisolid agar plates with (white bars) or without (black bars) the addition of PLP. Bars represent the mean determinations of
triplicatemeasurementsofcolonydiameterSEM(threeexperiments).**,P0.01,and***,P0.0001,asdeterminedbyStudent’sttest.(B)Bacterialmotility
in 6-h broth cultures was determined by visualization on a Leica AF6000 LX live-cell imager and analyzed using MetaMorph software. Data are presented as
means  SEM derived from over 400 positional data points for each strain (three experiments).
FIG 5 PdxA is required for functional ﬂagellar assembly and ﬂagellar glycosylation in H. pylori. (A to C) TEM micrographs of negatively stained H. pylori G27
wild-type (A), G27 pdxA (B), and G27 pdxA (pdxA) strains (C). Arrows indicate the ends of the ﬂagella in each strain. (D) Western blot of whole-cell lysates
(WCL) and sheared ﬂagellar preparations, detected with monoclonal anti-H. pylori 54-kDa ﬂagellin antibodies. (E) Detection of glycosylated proteins in WCL
andshearedﬂagellarpreparationsofH.pylori,oxidizedwithperiodateandvisualizedwithPro-QEmerald488reagent.Arrowsindicatethebandscorresponding
to FlaA.
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time, the importance of de novo vitamin B6 biosynthesis for host
colonization by a human pathogen. Vitamin B6 is an enzyme co-
factor in a plethora of cellular reactions, including transamina-
tion, decarboxylation, and racemization (reviewed in reference
19). PdxA and PdxJ catalyze two sequential reactions in the DXP-
dependent de novo vitamin B6 biosynthesis pathway (20); the by-
product of these reactions is pyridoxine-5=-phosphate (PNP)
(21). In turn, PNP is oxidized to form PLP, the bioactive vitamer
of vitamin B6 (22). The DXP-dependent pathway is found pre-
dominantlyinasmallsubsetofgammaproteobacteria(23–25)but
has been extensively studied only in E. coli (20–23). In H. pylori,
only the genes pdxJ and pdxA are annotated as belonging to the
pdx family and are clustered together on the H. pylori genome
(Fig. S2A). Interestingly, the genetic organization of pdxJ and
pdxA appears to be conserved for all Helicobacter and Campy-
lobacter spp., as well as for several other related organisms
(Fig. S2A). Conversely, these genes are spatially separated in all
other sequenced bacterial genomes containing the pdxJ and pdxA
genes,includingE.coli.Thus,thereappearstohavebeendivergent
evolution of bacterial vitamin B6 biosynthesis genes. We suggest
thatthisfurtherhighlightsthedifferencesbetweenthephysiology
of the model bacterium E. coli and those of other bacteria and
emphasizes the need to study the physiology of pathogenic bacte-
rial species.
Fromthedatapresentedhere,itappearsthatH.pyloripdxJand
pdxA are transcriptionally coregulated. This ﬁnding is consistent
with reports that both pdxA and pdxJ are repressed in the station-
ary phase of growth (26) but that both genes are induced by low
pH (pH 4.5) (27). Furthermore, these ﬁndings are in agreement
witharecentstudydescribingtheprimarytranscriptomeofH.py-
lori, where pdxJ and pdxA were found to be transcribed as an
operon(28).ThisfurthervalidatesPdxJandPdxAascolonization
factors for H. pylori, as low pH is encountered by H. pylori in its
preferred ecological niche (27). No differences in the upstream
DNA regions of pdxJ and pdxA were identiﬁed between low- and
high-infectivityvariantsofH.pyloriSS1(Fig.S2B),suggestingthat
transcriptionalrepressionbyaproximalcis-actingsequenceisun-
likely to be responsible for altered gene expression in the low-
infectivityvariants.Recently,anewlayerofcomplexityinH.pylori
gene expression and regulation, which is encoded by antisense
and/or trans-acting regulatory short RNAs, was uncovered (28)
andmaybethemechanismofregulationofpdxJandpdxAexpres-
sion. The reason for the reduced levels of gene expression in the
low-infectivity variants requires further investigation.
In this study, we identiﬁed H. pylori PdxA (HP1583) as being
essential for in vivo colonization of mice. We therefore reasoned
that the colonization defect of H. pylori pdxA mutants may be the
result of the loss of a PLP-dependent function involved in coloni-
zation. One such function is the glycosylation of ﬂagella, which is
necessaryformotilityandcolonizationinH.pylori(16–18).H.py-
loriglycosylatesitsﬂagellinswithapseudaminicacid(Pse)moiety,
synthesizedviaaPLP-dependentreactionmediatedbyPseC(16).
We therefore hypothesized that the absence of PLP in H. pylori
pdxA mutants may result in defective ﬂagellar synthesis. Indeed,
H.pyloripdxAmutantswerenonmotileandexpressednoﬂagella.
Furthermore, these mutants accumulated nonglycosylated ﬂagel-
linsoflowermolecularweightswithinthecytoplasm,indicativeof
an impairment in ﬂagellar glycosylation (Fig. 5A to E). Hence
impairmentofPseCactivity,duetoalackofavailablePLP,islikely
tobeonefactorcontributingtothecolonizationdefectofH.pylori
pdxA mutants.
ItiswidelyacceptedthatvitaminB6playsanimportantcellular
roleasanenzymecofactor.Toourknowledge,however,thisstudy
is the ﬁrst to describe a link between this vitamin and bacterial
pathogenesis. This ﬁnding is consistent with emerging evidence
supporting the importance of vitamin B6 in cellular processes in-
volved in the biosynthesis of surface-exposed structures that are
likely to contribute to adhesion and colonization in some patho-
genic bacteria (16, 29, 30). Indeed, PLP-dependent enzymes are
involved in the synthesis of surface-exposed glycosyl moieties,
such as ﬂagella and lipopolysaccharide (LPS), in Salmonella en-
terica serovar Typhimurium (29), Campylobacter jejuni (16),
Vibriocholerae(30),andE.coliO157:H7(30);LPSisnecessaryfor
efﬁcient bovine colonization by O157:H7 (30). It is worth noting
that in addition to the bacteria named above, the PdxJ/A-
dependentpathwayofvitaminB6biosynthesisispresentinseveral
otherhumanpathogens,includingNeisseriaspp.andYersiniapes-
tis, but is absent in mammals. Thus, this work identiﬁes PdxJ and
PdxA as novel potential therapeutic targets for the treatment of
infections by microbial pathogens. Indeed, various PLP-
dependent enzymes have already been identiﬁed as drug targets
for the treatment of a diverse range of diseases (20–22). We sug-
gest that the disruption of de novo PLP biosynthesis per se, via the
inhibition of PdxJ/A, offers the added advantage of selectively in-
hibiting microbial growth without nonspeciﬁcally affecting vital
host cell functions. Thus, this study opens new avenues for the
treatment of microbial infections.
MATERIALS AND METHODS
Bacterial strains and culture conditions. Bacterial strains used in this
studyarelistedinTableS1inthesupplementalmaterial.H.pyloriisolates
were routinely subcultured as previously described (31). For in vitro
growthstudies,H.pyloribacteriaweregrownforupto24hin10mlbrain
heart infusion (BHI; Oxoid) broth supplemented or not supplemented
with10mg/literPLP(Sigma).Viablecellcountsandopticaldensity(A600)
determinations were performed at the selected time points. E. coli strains
were grown in Luria-Bertani (LB) broth or on LB agar (containing 1.5%
[wt/vol] agar) supplemented with kanamycin (20 mg/liter), ampicillin
(100 mg/liter), or chloramphenicol (25 mg/liter), as appropriate.
Infection of mice with H. pylori. Animal handling and experimenta-
tionwereperformedinaccordancewithnationalandinstitutionalguide-
lines (French Laws 87 to 848 and Monash University AEC no. BAM/
M2005/44, respectively). H. pylori suspensions for mouse inoculation
were prepared directly in broth (31). Six- to eight-week-old female
speciﬁc-pathogen-freemicewereeachintragastricallyadministeredasin-
gle 100-l aliquot of the inoculating suspension (107 CFU/mouse) using
polyethylene catheters (31).
Assessment of H. pylori infection in mice. The presence of H. pylori
infection in mice was determined by quantitative culture, detection of
anti-H. pylori antibodies in sera, and/or RT-PCR on RNA isolated from
gastric biopsy specimens, as previously described (31).
Molecularbiologytechniques.GenomicandplasmidDNAwereiso-
lated using the Masterpure DNA puriﬁcation (Epicentre) and PureLink
plasmid midi kits (Invitrogen), respectively. Restriction endonuclease di-
gestions,ligations,andotherenzymaticreactionswereconductedbystan-
dard procedures as described by Sambrook et al. (32).
Macroarray analyses. Macroarrays (Eurogentec, SA, Belgium), con-
sisting of the complete set of genes from the H. pylori 26695 strain, were
hybridized to [-33P]dCTP-labeled cDNA which had been reverse tran-
scribedfromRNAisolatedfrompairedliquidculturesofhigh(17to23in
vitropassages)-orlow(180to192passages)-infectivityH.pyloriSS1vari-
ants (33). The intensities of hybridizing spots from four independent
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COSE (33). Signiﬁcant differences in gene expression were determined
using the program signiﬁcance analysis of macroarrrays (SAM) (34).
RNA isolation. Mouse gastric biopsy specimens, stored in RNA later
(Ambion), were placed in TRIzol reagent (Invitrogen) and homogenized
on ice using a PRO-200 homogenizer (PRO Scientiﬁc, CT). RNA was
puriﬁed from gastric biopsy specimens or harvested H. pylori bacteria
(107 CFU) using TRIzol reagent and Phase Lock gel tubes (Eppendorf)
and then DNase treated using RQ1 DNase (Promega). RNA was subse-
quently puriﬁed using the RNeasy minikit (Qiagen).
qRT-PCR. RNA (200 ng to 2 g) was reverse transcribed using ran-
dom hexamers and SuperScript III (Invitrogen). Primers (Table S2) were
designedbasedontheH.pylori26695genomicDNAsequence(GenBank
accessionno.AE000511)usingthePrimerExpressprimerdesignsoftware
(Applied Biosystems). qRT-PCR was performed as previously described
(35). cDNA concentrations of the target genes for each sample were nor-
malized to expression of the housekeeping gene, uvrC (26).
Construction of H. pylori mutants by allelic exchange. PCR frag-
ments, ampliﬁed using the primers listed in Table S2 in the supplemental
material, were puriﬁed and then ligated into pILL570 or pGEM-T Easy
(Promega). Constructs were ampliﬁed by inverse PCR (Failsafe PCR Sys-
tem; Epicentre) using primers SL7 and SL8, SL3 and SL4, or SL12 and
SL13,respectively.ThedigestedPCRproductswereligatedwithaBamHI/
KpnI-digestednonpolarkanamycinresistancecassette(aphA3)(13).The
construct used to inactivate the vacA paralog gene was generated by PCR
with the 3T primer pool (3T-PCR), using the oligonucleotides H206,
H207, H208, and H209 (Table S2). Isogenic H. pylori mutants were cre-
ated by either electroporation (36) or natural transformation (37) and
selectedonhorsebloodagar(HBA)platescontainingkanamycin(20mg/
liter). PLP was added to media used to culture H. pylori pdxA mutant
strains. Kanamycin-resistant transformants in each strain of H. pylori
were veriﬁed by sequencing and PCR analyses (primer H17 or H50) (Ta-
ble S2).
Complementation of H. pylori pdxA mutants. A 150-bp fragment
containing the H. pylori 26695 ureA promoter sequence was ampliﬁed by
PCR from the pUGO plasmid (M. Kaparakis-Liaskos, unpublished data)
using primers AG14F and AG14R (Table S2). H. pylori pdxA was ampli-
ﬁed from H. pylori 26695 chromosomal DNA using primers AG15F and
AG5R. The partially complementary PCR products (1 ng) were used as
templates in splicing by overlap extension (SOE) PCR, consisting of ﬁve
cycles of 94°C for 1 min, 35°C for 1 min, and 72°C for 2 min without the
addition of primers, followed by 35 cycles of 94°C for 1 min, 50°C for
1 min, and 72°C for 2 min in the presence of 20 pmol of each of the
primers AG14F and AG5R. The resultant PCR products were cloned into
the BamHI/EcoRI sites of the linearized pRdxA vector (38). Comple-
mented H. pylori pdxA mutants were selected on HBA plates supple-
mented with metronidazole (8 mg/liter) in the absence of PLP. These
mutantswereveriﬁedbyPCRsequencingusingtheprimersAG1F,AG1R,
AG5F, and AG5R.
DetectionofantibodiesbyELISA.H.pyloriantigen-speciﬁcantibod-
iesinmouseserumsamplesweredetectedbyenzyme-linkedimmunosor-
bentassay(ELISA)(39).BoundH.pylori-speciﬁcimmunoglobulinswere
detected with biotinylated goat anti-mouse antibodies (IgM -chain
[Millipore] or IgG [Jackson ImmunoResearch Laboratories, Inc.]) and
streptavidin-peroxidase conjugate (Chemicon).
Cross-complementation in E. coli. pdxA and pdxJ were ampliﬁed
from H. pylori 26695 genomic DNA using the primers AG5F and AG5R
and AG6F and AG6R, respectively, and ligated into the BamHI/EcoRI-
linearizedpET28avector(Novagen).Theseplasmidsweretransformedby
electroporation (40) into E. coli CGSC8631 (pdxA) and CGSC10027
(pdxJ) and selected on Glu B1 56/2 minimal medium (41), supplemented
or not supplemented with PLP and IPTG (1 mM).
Motility testing. Bacterial motility was determined using semisolid
agar plates (17). The velocities of individual bacteria were determined by
differentialinterferencecontrast(DIC)imagingusinganIntegratedLeica
AF6000LXlive-cellworkstation(LeicaMicrosystems).Aliquots(10l)of
H. pylori (5  107 CFU/ml), which had been harvested from 6-h liquid
broth cultures supplemented or not with PLP, were prepared in 0.4%
methylcellulose in a FluoroDish (World Precision Instruments Inc.). Im-
age analysis was performed using MetaMorph software (Molecular De-
vices). For each experiment, positional data for 20 bacteria over a mini-
mum of 20 frames each were used to determine average velocity.
Electron microscopy. Bacteria were applied to Formvar-carbon-
coated copper grids (400 mesh) and negatively stained for 5 to 10 s with
1% phosphotungstic acid (pH 6.8). Grids were examined using a Hitachi
H-7500 transmission electron microscope.
Flagellin preparation. Flagella were isolated according to a modiﬁed
methodofReevesetal.(42).Brieﬂy,bacteriawereharvestedfrom500-ml
liquid cultures, resuspended in phosphate-buffered saline (PBS), and
sheared for 1 min with an MSE homogenizer (MSE Ltd.). Cell debris was
removed by centrifugation, and ﬂagella were concentrated from the su-
pernatants by ultracentrifugation using a TH-641 rotor in the Sorvall
RC-90 ultracentrifuge (285,000  g f o r1ha t10°C). Pellets containing
ﬂagella were resuspended in 100 l Milli-Q H2O. Protein concentrations
were determined by the Bradford (Bio-Rad) or Qubit (Invitrogen) assay.
SDS-PAGE and Western blotting. Samples were separated in 10 to
12.5%(vol/vol)acrylamidegelsandtransferredtonitrocellulose.Flagellin
was detected using mouse monoclonal antibodies to the H. pylori 54-kDa
ﬂagellin antigen (Bioscientiﬁc), followed by biotinylated secondary goat
anti-mouse IgG antibodies (Chemicon) and streptavidin-horseradish
peroxidase (HRP) (Chemicon). Antigen-antibody complexes were de-
tected using ECL detection reagent (GE Healthcare). Glycosylated pro-
teinsweredetectedusingthePro-QEmerald488glycoproteingelandblot
stain kit (Invitrogen).
Statistics. Differences in colonization levels between low- and high-
infectivity H. pylori SS1 variants were determined using contingency ta-
bles (Fisher’s exact test). Differences in the bacterial loads or antibody
responsesbetweenanimalgroupsweredeterminedbytheMann-Whitney
U test (two-sided). Differences in expression levels determined by qRT-
PCR were analyzed using the Student t test. Differences were considered
signiﬁcant when P was 0.05.
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